Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 20, 2026
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 20, 2026
Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007).
Journal: Journal of the National Cancer Institute
Published: February 06, 2026
Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2).
Journal: NPJ breast cancer
Published: November 28, 2025
Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline.
Journal: Annals of surgical oncology
Published: September 16, 2025
Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 16, 2025
Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline.
Journal: Practical radiation oncology
Published: September 16, 2025
Investigating initial patterns of progression on first-line treatment in patients with de novo metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: September 11, 2025
Pertuzumab and Pathological Complete Response in Early HER2+ Breast Cancer: A Systematic Review and Meta-analysis of Real-World Studies.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: July 07, 2025
Prognostic role of miR-190, miR-221, and miR-381 in breast cancer: a systematic review and meta-analysis.
Journal: European review for medical and pharmacological sciences
Published: July 04, 2025
Prognostic utility of inflammatory indices and circulating nucleic acids for neoadjuvant chemotherapy outcomes in breast cancer: a systematic review.
Journal: Therapeutic advances in medical oncology
Published: June 23, 2025
Last Updated: 09/26/2026